Femasys Inc (FEMY)

Currency in USD
4.1700
-0.1800(-4.14%)
Closed·
4.17000.0000(0.00%)
·
Advertisement
FEMY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.17004.7800
52 wk Range
3.500022.2000
Key Statistics
Prev. Close
4.35
Open
4.415
Day's Range
4.17-4.78
52 wk Range
3.5-22.2
Volume
65.42K
Average Volume (3m)
61.56K
1-Year Change
-77.6119%
Book Value / Share
2.41
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FEMY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
63.3333
Upside
+1,418.78%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Femasys Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 63.3333
(+1,418.78% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Lake Street
Buy1.50-64.03%-New Coverage03/03/2026
Laidlaw
Buy6.50+55.88%-New Coverage20/11/2025

Earnings

Latest Release
08/05/2026
EPS / Forecast
-- / -1.80
Revenue / Forecast
424.89K / 605.5K
EPS Revisions
Last 90 days

Compare FEMY to Peers and Sector

Metrics to compare
FEMY
Peers
Sector
Relationship
P/E Ratio
−1.0x−5.3x−0.4x
PEG Ratio
−0.01−0.310.00
Price/Book
1.7x4.4x2.6x
Price / LTM Sales
5.3x2.9x3.0x
Upside (Analyst Target)
-51.2%49.1%
Fair Value Upside
Unlock7.5%6.1%Unlock

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women’s reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women’s healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
108.22K3.58%451.29K
Other Institutional Investors
579.11K19.18%2.41M
Public Companies & Retail Investors
2.33M77.24%9.73M
Total
3.02M100.00%12.59M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dauntless Investment Group, Llc9.99%301,6511,258
Alumni Capital LP7.90%238,679995

People Also Watch

10.4100
AKTX
+1.56%
4.300
HCWB
-6.11%
1.270
EZGO
-2.31%
0.357
NXXT
-4.04%
28.260
CUE
-0.28%

FAQ

What Is the Femasys (NASDAQ: FEMY) Share Price Today?

The Femasys stock price today is 4.1700 USD.

What Stock Exchange Does Femasys (FEMY) Trade On?

Femasys is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Femasys?

The stock symbol (also called a 'ticker') for Femasys is "FEMY."

What Is the Current Femasys Market Capitalisation?

As of today, Femasys (NASDAQ: FEMY) market cap is 12.5900M USD.

What Is Femasys's (FEMY) Earnings Per Share (TTM)?

The Femasys EPS is currently -5.0137 (Trailing Twelve Months).

When Is the Next Femasys Earnings Date?

Femasys's next earnings report will be released on 12/08/2026.

Is FEMY a Buy or Sell From a Technical Analyst Perspective?

Based on today's Femasys moving averages and other technical indicators, the daily buy/sell signal for FEMY stock is Sell.

How Many Times Has Femasys Stock Split?

Femasys has split 1 times. (See the FEMY stock split history page for full effective split date and price information.)

How Many Employees Does Femasys Have?

Femasys has 53 employees, based on their latest Companies House report.

What is the current trading status of Femasys (NASDAQ: FEMY)?

As of 04/07/2026, Femasys (FEMY) is trading at a share price of 4.1700 USD, with a previous close of 4.3500 USD. The stock has fluctuated within a day range of 4.1700 USD to 4.7800 USD, while its 52-week range spans from 3.5000 USD to 22.2000 USD.

What Is Femasys (FEMY) Price Target According to Analysts?

The average 12-month price target for Femasys is 63.3333 USD, with a high estimate of 130 USD and a low estimate of 30 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +1,418.78% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.